News & Media

Industry news curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Activism

CorpGov: Barshay Says Lina Khan Can't Sue Everybody

By Tom Terrarosa
|
Published: October 1st, 2021
The powerhouse corporate attorney handed out some advice to companies, ESG investors and the broader investment community at The Deal's Corporate Governance 2021 conference.
Activism

Drinks With The Deal: Willkie's Tariq Mundiya

By David Marcus
|
Published: December 2nd, 2021
Willkie head of litigation Tariq Mundiya discusses the Williams poison pill case from earlier this year as well as the CytoDyn decision and the evolution of Delaware's Caremark doctrine in this week's Drinks With The Deal podcast.
Mergers & Acquisitions

Drinks With The Deal: Squire Patton Boggs' James Barresi

By David Marcus
|
Published: November 18th, 2021
James Barresi, who heads the firm's financial services practice, explains how his time as an in-house lawyer at US Bancorp in the 1990s has shaped his approach to private practice and how he works with clients considering a deal.
Mergers & Acquisitions

Book Review: Consider the Cocktail

By David Marcus
|
Published: November 4th, 2021
The new 'Oxford Companion to Spirits & Cocktails' treats the beverages in all of their aspects from production to history to brand management.
Podcasts

Fresh Start: Professor Melissa Jacoby

By Stephanie Gleason
|
Published: October 25th, 2021
The University of North Carolina at Chapel Hill professor discusses finding the boundaries of bankruptcy in Purdue and more on the latest episode of Fresh Start.
Mergers & Acquisitions

Drinks With The Deal: Krishna Veeraraghavan of Paul Weiss

By David Marcus
|
Published: October 14th, 2021
M&A lawyer Krishna Veeraraghavan talked about healthcare dealmaking and the risks of excessive antitrust regulation of combinations between biotech and pharma companies in the Drinks With The Deal podcast.
Mergers & Acquisitions

OpEd: ESG in Due Diligence Is Not Just Another Box to Check

By Deal Contributors
|
Published: October 5th, 2021
With ESG now a day-to-day focus for management and directors across industries, companies would be well-served to undertake a thoughtful assessment of ESG risks when evaluating potential targets in M&A activities.